Cho Youl-hee | Department Of Medical Genetics College Of Medicine Hanyang University
スポンサーリンク
概要
- CHO Youl-Heeの詳細を見る
- 同名の論文著者
- Department Of Medical Genetics College Of Medicine Hanyang Universityの論文著者
関連著者
-
KIM Min
Department of Internal Medicine, Chonnam National University Hospital
-
Cho Youl-hee
Department Of Medical Genetics College Of Medicine Hanyang University
-
Kim Min
Department Of Medical Genetics College Of Medicine Hanyang University
-
Kim Min
Department Of Chemical Engineering Cheju National University
-
LEE Chul-Hoon
Department of Medical Genetics, College of Medicine, Hanyang University
-
Lee Chul-hoon
Department Of Medical Genetics College Of Medicine Hanyang University
-
Kim Min
Department of Applied Science, Korea Maritime University, Busan 606-791, Korea
-
KIM Min
Department of Animal Science and Biotechnology, College of Agriculture and Life Science, Chungnam National University, Daejeon 305–764, Korea
-
Park Hae
Department of Obstetrics and Gynaecology, College od Medicine, Soonchunhyang University
-
Park Hae
Department Of Neuropsychiatry Seoul National University Hospital
-
Lim Haeyoung
Department Of Medical Genetics College Of Medicine Hanyang University
-
OH Ha
Department of Medical Genetics, College of Medicine, Hanyang University
-
CHOI Bu-Young
Department of Molecular Biology and Pharmacology, C&C Research Laboratories
-
MOON Sang-Ik
Department of Medical Genetics, Hanyang University College of Medicine
-
Moon Sang-ik
Department Of Medical Genetics Hanyang University College Of Medicine
-
Oh Ha
Department Of Medical Genetics College Of Medicine Hanyang University
-
Choi Bu-young
Department Of Molecular Biology And Pharmacology C&c Research Laboratories
-
Park Hae
Department Of Urology Hanyang University College Of Medicine
-
Park Hae
Department of Metallurgical Engineering, Yonsei University, Seodamoon, Shinchon 134, Seoul 120-749, Korea
著作論文
- CR229, a novel derivative of β-carbolin-1-one, induces cell cycle arrest and apoptosis in HeLa cells via p53 activation
- Cell cycle arrest and apoptotic induction in LNCaP cells by MCS-C2, novel cyclin-dependent kinase inhibitor, through p53/p21^ pathway